BMY - NYSE - 3/12/2010 8:00 PM
| Current | Overall Rank | Sector Rank | Industry Rank |
|---|---|---|---|
| N/A | N/A / 4566 | N/A / 503 | N/A / 18 |
| Healthcare | Drug Manufacturers - Major |
| Period | Profit Margin |
|---|---|
| Sep/99 | 21.77% |
| Dec/99 | 19.45% |
| Mar/00 | 23.21% |
| Jun/00 | 20.68% |
| Sep/00 | 27.09% |
| Dec/00 | 21.16% |
| Mar/01 | 28.49% |
| Jun/01 | 25.50% |
| Sep/01 | 26.25% |
| Dec/01 | 27.70% |
| Mar/02 | 14.33% |
| Jun/02 | 10.86% |
| Sep/02 | 7.53% |
| Dec/02 | 7.80% |
| Mar/03 | 16.15% |
| Jun/03 | 17.38% |
| Sep/03 | 16.56% |
| Dec/03 | 7.70% |
| Mar/04 | 18.61% |
| Jun/04 | 9.71% |
| Sep/04 | 13.97% |
| Dec/04 | 2.70% |
| Mar/05 | 13.70% |
| Jun/05 | 20.54% |
| Sep/05 | 20.22% |
| Dec/05 | 9.94% |
| Mar/06 | 15.27% |
| Jun/06 | 13.69% |
| Sep/06 | 8.14% |
| Dec/06 | -3.18% |
| Mar/07 | 15.42% |
| Jun/07 | 14.33% |
| Sep/07 | 16.99% |
| Dec/07 | -1.65% |
| Mar/08 | 12.76% |
| Jun/08 | 14.68% |
| Sep/08 | 49.07% |
| Dec/08 | 23.70% |
| Mar/09 | 12.72% |
| Jun/09 | 18.26% |
| Sep/09 | 17.61% |
Perspectives on Strategic M&A in Pharma by Pfizer Inc. Capital IQ Monthly Market Observations 03/10. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about a day ago.
Pharma trend: looking at complementary or diversified businesses. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about a day ago.
Pharma trend: Huge growth in emerging markets like China. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about a day ago.
Pharma trend:Pfizer/Wyeth,Merck/Schering,Roche/Genentech. cost synergy. diversifying revenue. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY
HometownStocks about a day ago.
Pharma trend: Revenue declines. Return on R&D declines. Industry consolidation. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about a day ago.
Pharma trend: Generic’s are the winners when things go off the patent. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about a day ago.
Pharma trend: loss of exclusivity, $314B in products patent expire in next 5 yrs. keynote by Kristin Peck.$PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about a day ago.
A Black-Box Warning for Plavix. Confusion May Follow (at The Wall Street Journal Online)
Mar 12 05:42 PM EST.
RT @mhuckman: While in the air,bloodthinner Plavix from Bristol&Sanofi $BMY $SNY got new boxed warning. FDA doesn't want us 2 call it 'black box' anymore.
blehr11 about 2 days ago.
RT @mhuckman: While in the air,bloodthinner Plavix from Bristol&Sanofi $BMY $SNY got new boxed warning. FDA doesn't want us 2 call it 'black box' anymore.
IJALM about 2 days ago.
While in the air,bloodthinner Plavix from Bristol&Sanofi $BMY $SNY got new boxed warning. FDA doesn't want us 2 call it 'black box' anymore.
mhuckman about 2 days ago.
Mar 12 01:08 PM EST.
Interesting BioSante GVAX data in leukemia targets minimal residual disease post imatinib therapy http://bit.ly/96tBLZ $BPAX $NVS $BMY
MaverickNY about 3 days ago.
$BMY (Bristol-Myers Squibb) $25.89 crossed its 1st Pivot Point Resistance #emppv #stocks http://empirasign.com/s/7y8
empirasign_eq about 3 days ago.
RT @mhuckman: Small co, small study fyi RT @MaverickNY: My take on the BioSante GVAX data in leukemia: http://bit.ly/96tBLZ $BPAX $NVS $BMY
Newbietrader1 about 3 days ago.
Small co, small study fyi RT @MaverickNY: My take on the BioSante GVAX data in leukemia: http://bit.ly/96tBLZ $BPAX $NVS $BMY
mhuckman about 3 days ago.
My take on the BioSante GVAX data in leukemia: http://bit.ly/96tBLZ $GPAX $NVS $BMY
MaverickNY about 3 days ago.
$BMY (Bristol-Myers Squibb) $25.62 crossed its 3rd Pivot Point Resistance #emppv #stocks http://empirasign.com/s/7e8
empirasign_eq about 4 days ago.
Biotechs Jump on Facet, Intermune Deal - Stocks To Watch Today - Barrons.com $ITMN $ABT $FACT $OSIP $JNJ $BMY $BSX $XBI http://bit.ly/aJDahM
barronsstocks about 4 days ago.
RT @MaverickNY: The Abbott-Facet Biotech deal: Let the dance begin http://bit.ly/bJF2eH $ABT $FACT $BMY $BIIB
WriterChik about 4 days ago.
Abbot Bids 66% Premium for Facet’s Oncology Drugs - Stocks To Watch Today - Barrons.com $ABT $FACT $JNJ $PFE $BSX $BMY http://bit.ly/cEfsR7
barronsstocks about 4 days ago.
RT @mhuckman: 1 more thing on Bristol $BMY CEO $1.5m pay cut last yr. Still made $18.2m, but said @ analyst mtg last wk he'll soon "b on fixed income."
mccannpj about 4 days ago.
1 more thing on Bristol $BMY CEO $1.5m pay cut last yr. Still made $18.2m, but said @ analyst mtg last wk he'll soon "b on fixed income."
mhuckman about 4 days ago.
RT @odomlewis: RT @mhuckman: How's this 4 a change? Bristol $BMY says CEO Cornelius took $1.5m pay cut last yr. Still made $18.2m[obscene]
MeredithGould about 4 days ago.
RT @mhuckman: How's this 4 a change? Bristol $BMY says CEO Cornelius took $1.5m pay cut last yr. Still made $18.2m, tho.
odomlewis about 4 days ago.
The Abbott-Facet Biotech deal: Let the dance begin http://bit.ly/bJF2eH $ABT $FACT $BMY $BIIB
MaverickNY about 4 days ago.
Looking forward to participating in SXSWi panel "Data Is Money" with @apatzer, @womanwportfolio, Jesper Anderson, Allison Brady #datamoney
about 23 hours ago. | Follow Us
